跳至主要内容
临床试验/NCT00944814
NCT00944814已完成不适用

Assessment of the Acceptability of Zinc-fortified Lipid Based Nutrient (LNS) Prepared for Young Burkinabe Children

University of California, Davis1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2009年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
1
主要终点
Preference and detection of differences between LNS formulations among mothers

研究概览

简要总结

The purpose of the study is to assess the acceptability of the two lipid-based nutrient supplement (LNS) formulations containing no zinc and a high amount of zinc (10 mg zinc / 20 g dose of LNS). The hypothesis is that both products will be equally accepted by children and mothers.

详细描述

We plan to conduct a series of acceptability studies to: 1) assess the amounts of zinc-free and high-zinc LNS consumed by children during direct observation, 2) compare their mothers' sensory assessments of the respective products, and 3) review maternal reports of their child feeding experiences during more prolonged home feeding trials.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
9 Months 至 15 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Currently breast-feeding and consuming complementary foods for at least 30 d

排除标准

  • Height-for-age and weight-for height Z-scores <-3 with respect to WHO growth standards
  • Diarrhea and other diseases that could interfere with food intake
  • Severe systemic illness
  • History of peanut allergy
  • History of anaphylaxis/serious allergic reaction
  • Infants meeting these criteria and their mother's will be invited to participate

结局指标

主要结局

Preference and detection of differences between LNS formulations among mothers

时间窗: 3 days

Acceptability of feeding LNS to young children at home

时间窗: 2 weeks

Amount of each type of LNS formulation consumed by young children

时间窗: 3 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Acceptability of Zinc-fortified Lipid-based Nutrient... | 临床试验